Maine Legislative Bill Challenges Step Therapy, Which Allows Insurers to Make Care Decisions
Source: Pixabay

Maine Legislative Bill Challenges Step Therapy, Which Allows Insurers to Make Care Decisions

Many medical insurers follow a practice known as step therapy. A new law presented to legislators in Maine proposes to protect patients from such practices. In her column for Central…

Continue Reading Maine Legislative Bill Challenges Step Therapy, Which Allows Insurers to Make Care Decisions
Man With Soft Tissue Sarcoma is Refusing to Let His Diagnosis Spoil His Recent Marriage
source: pixabay.com

Man With Soft Tissue Sarcoma is Refusing to Let His Diagnosis Spoil His Recent Marriage

According to a story from the Peterborough Telegraph, James Willis received a disaster diagnosis on his first Valentine's Day after getting married at age 29. James had been worried about…

Continue Reading Man With Soft Tissue Sarcoma is Refusing to Let His Diagnosis Spoil His Recent Marriage
Australian Boy With Spinal Muscular Atrophy is Now Able to Get Critical Treatment
https://pixabay.com/en/autumn-fall-baby-boy-child-cute-275920/

Australian Boy With Spinal Muscular Atrophy is Now Able to Get Critical Treatment

According to a story from the Sydney Morning Herald, two-year-old William McLennan, son of Naomi Taylor and Ben McLennan, was diagnosed with spinal muscular atrophy about a year ago. The…

Continue Reading Australian Boy With Spinal Muscular Atrophy is Now Able to Get Critical Treatment
An Experimental Treatment for FSHD Has Been Awarded Fast Track Designation by the FDA
RobinHiggins / Pixabay

An Experimental Treatment for FSHD Has Been Awarded Fast Track Designation by the FDA

Acceleron Pharma has just received Fast Track designation from the US Food and Drug Administration (FDA) for their experimental treatment ACE-083 designed to treat patients with facioscapulohumeral muscular dystrophy (FSHD).…

Continue Reading An Experimental Treatment for FSHD Has Been Awarded Fast Track Designation by the FDA
New Collaboration Will Test Experimental Clinical Trial Designs for Stargardt Disease Drugs
source: pixabay.com

New Collaboration Will Test Experimental Clinical Trial Designs for Stargardt Disease Drugs

According to a story from pharmavoice.com, a new partnership between the biotechnology company Vitrisa Therapeutics and the Foundation Fighting Blindness Clinical Research Institute (FFB-CRI) is in the works in order…

Continue Reading New Collaboration Will Test Experimental Clinical Trial Designs for Stargardt Disease Drugs
The UK Parliament Met With a Mother Advocating For Duchenne Muscular Dystrophy Patients
Source: Pixabay

The UK Parliament Met With a Mother Advocating For Duchenne Muscular Dystrophy Patients

Phillippa Farrant, whose son, Daniel, has been diagnosed with Duchenne muscular dystrophy (DMD), recently appeared in Parliament in the UK to fight for improved access to care and treatment for…

Continue Reading The UK Parliament Met With a Mother Advocating For Duchenne Muscular Dystrophy Patients
A Gene Therapy Being Developed for Sanfilippo Syndrome Has Been Granted RMAT status in the US.
Source: Pixabay

A Gene Therapy Being Developed for Sanfilippo Syndrome Has Been Granted RMAT status in the US.

A gene therapy being developed as a treatment for Sanfilippo syndrome has just been awarded Regenerative Medicine Advanced Therapy (RMAT) status in the US, reports GlobalGenes. Sanfilippo syndrome is a…

Continue Reading A Gene Therapy Being Developed for Sanfilippo Syndrome Has Been Granted RMAT status in the US.